These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29722190)
21. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience. Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378 [No Abstract] [Full Text] [Related]
22. Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer. Gordon CL; Buntine JA; Hayman JA; Lavender CJ; Fyfe JA; Hosking P; Johnson PD PLoS Negl Trop Dis; 2011 Oct; 5(10):e1290. PubMed ID: 22039555 [No Abstract] [Full Text] [Related]
23. Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease. Taxonera C; Mendoza JL; Ortega L; Pérez MI; Díaz-Rubio M J Crohns Colitis; 2012 May; 6(4):488-91. PubMed ID: 22398051 [TBL] [Abstract][Full Text] [Related]
24. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938 [TBL] [Abstract][Full Text] [Related]
25. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report. Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530 [TBL] [Abstract][Full Text] [Related]
26. Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond? Fiorino G; Danese S J Crohns Colitis; 2016 Nov; 10(11):1257-1258. PubMed ID: 27389085 [No Abstract] [Full Text] [Related]
27. Diagnosis of Mycobacterium ulcerans disease: be alert to the possibility of negative initial PCR results. O'Brien DP; Globan M; Fyfe JM; Lavender CJ; Murrie A; Flanagan D; Meggyesy P; Priestley JT; Leslie D Med J Aust; 2019 May; 210(9):416. PubMed ID: 30802309 [No Abstract] [Full Text] [Related]
29. A retrospective comparison of infliximab versus adalimumab as induction and maintenance therapy for Crohn disease. Varma P; Paul E; Huang C; Headon B; Sparrow MP Intern Med J; 2016 Jul; 46(7):798-804. PubMed ID: 26865349 [TBL] [Abstract][Full Text] [Related]
30. Down-titration of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study. Piaserico S; Gisondi P; De Simone C; Marinello E; Conti A; Amerio P; Peserico A Acta Derm Venereol; 2016 Feb; 96(2):251-2. PubMed ID: 26270599 [No Abstract] [Full Text] [Related]
31. A cutaneous presentation of a common condition. Daunton A; Langman G; Goulding JM BMJ; 2015 Dec; 351():h6711. PubMed ID: 26681202 [No Abstract] [Full Text] [Related]
32. Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitis. Kiely CJ; Subramaniam K; Platten J; Pavli P Intern Med J; 2016 May; 46(5):616-9. PubMed ID: 27170239 [TBL] [Abstract][Full Text] [Related]
34. Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease. Emmert MY; Salzberg SP; Emmert LS; Behjati S; Plass A; Felix C; Falk V; Gruenenfelder J Eur J Heart Fail; 2009 Nov; 11(11):1106-9. PubMed ID: 19875411 [TBL] [Abstract][Full Text] [Related]
35. Buruli ulcer accompanied by pain in a Japanese patient. Onoe H; Yotsu RR; Nakanaga K; Hoshino Y; Ishii N; Takeuchi T J Dermatol; 2012 Oct; 39(10):869-70. PubMed ID: 22168180 [No Abstract] [Full Text] [Related]
36. The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series. Jerjen R; Moodley A; Sinclair R Australas J Dermatol; 2020 Nov; 61(4):376-377. PubMed ID: 32578188 [No Abstract] [Full Text] [Related]
37. WHO takes a new approach to Buruli ulcer. Barksby R Lancet Infect Dis; 2019 May; 19(5):473-474. PubMed ID: 31034395 [No Abstract] [Full Text] [Related]
38. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis. Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935 [TBL] [Abstract][Full Text] [Related]
40. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease. Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]